Today: 9 June 2026
Natural Gas Gains as Output Slips and an Early Heat Wave Builds
15 May 2026
2 mins read

Natural Gas Gains as Output Slips and an Early Heat Wave Builds

NEW YORK, May 15, 2026, 13:22 (EDT)

U.S. natural gas futures jumped Friday, rising almost 3% to their highest level in seven weeks. Prices hit $2.96 per million British thermal units (mmBtu), up 2.31% on the day. Traders pointed to lighter production and expectations for milder weather as the main catalysts. Reuters highlighted the 3% move and tied it to falling output.

As the spring “shoulder season” fades—the gap between peak winter heating demand and the summer air-conditioning climb—market attention is shifting. Output has eased even as power demand starts to pick up, quickly tightening the day-to-day supply-demand balance.

U.S. natural gas storage is still building at a solid clip. The latest U.S. Energy Information Administration data shows working gas in underground storage increased by 85 billion cubic feet for the week ending May 8 to 2,290 Bcf. That is 51 Bcf higher than this time last year and 140 Bcf above the five-year average.

Bulls stuck around. Barchart data on Thursday showed an 85-Bcf build, short of analyst expectations for a 91-Bcf injection. Commodity Weather Group also flagged a warming trend in the Midwest through May 18, which could lift gas demand for power generation as cooling needs start to build.

Analysts had been bracing for the demand shift. Eli Rubin of EBW Analytics said a “seasonal upside” looked likely at the start of summer. At Pinebrook Energy Advisors, Andy Huenefeld said lower-priced 2026 gas was driving more gas-fired generation. The Wall Street Journal

Bulls are still running into firm limits. In its latest outlook, released in May, the EIA projects U.S. dry gas production will reach 110.61 Bcf per day by 2026, from 107.65 Bcf/d next year. Storage builds are expected to stay above average from April through October. For Q2, the forecast sees Henry Hub at $2.83/mmBtu. The agency also expects inventories to finish injection season 7% above the five-year norm.

For producers including EQT and integrated majors like Exxon Mobil, the backdrop is mixed. Stronger Henry Hub pricing usually boosts upstream revenue, but the impact on results can get muddied quickly—hedging strategies, oil-linked contracts, and regional price spreads all complicate the picture. For LNG-focused firms like Cheniere, firm export demand helps counter hefty domestic supply. The EIA projects U.S. LNG exports to average 17.0 Bcf/d this year.

At the open, prediction markets for natural gas showed a bullish tilt, though trading was thin. On Kalshi, contracts put the odds at 92% that prices would settle above $2.899 by 5 p.m. EDT. The chance of a close above $2.999 was just 16%. Total volume was $17,577.

On May 15, natural gas bulls were firmly in control on Polymarket, with traders pricing in a 92% chance of a higher close and pushing about $3,000 through the market. In another active contract, the odds of gas touching $3.00 at any point in May were near 89%.

Gas is still abundant. Production could bounce back, LNG feedgas demand may soften, or a cooler weather forecast could quickly put storage back at the center of the trade, risking a lid on the rally traders shrugged off on Friday.

Balance, not panic, is setting the tone. Production has edged lower, weather is offering some support, and the latest storage build still hasn’t done enough to hand sellers the upper hand.

Stock Market Today

  • SailPoint Q1 Earnings Beat Estimates Amid Revenue Growth
    June 9, 2026, 10:14 AM EDT. SailPoint, Inc. (SAIL) reported Q1 earnings of $0.05 per share, surpassing the Zacks Consensus Estimate of $0.04 by 17.65%. Revenue increased to $280.14 million, beating estimates by 1.41% and up from $230.47 million a year ago. Despite earnings surprises and revenue growth, SailPoint shares have declined 12.6% year-to-date against the S&P 500's 8.2% rise. The company holds a Zacks Rank #3 (Hold), indicating expected market-aligned performance. Consensus estimates forecast Q2 EPS of $0.08 on $310.79 million revenue and fiscal year EPS of $0.32 on $1.27 billion revenue. Industry trends in the Zacks Internet-Software sector will influence future stock performance. Investors await management's commentary for guidance on sustainability.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Grab Stock Just Hit a Fresh 52-Week Low — Why Investors Still Aren’t Buying the Profit Beat
Previous Story

Grab Stock Just Hit a Fresh 52-Week Low — Why Investors Still Aren’t Buying the Profit Beat

Volvo, DSV Begin First Driverless Freight in Texas; Aurora Innovation’s AUR Faces Real-World Trial
Next Story

Volvo, DSV Begin First Driverless Freight in Texas; Aurora Innovation’s AUR Faces Real-World Trial

Go toTop